MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Anika Therapeutics Inc

Открыт

СекторЗдравоохранение

14.06 0.43

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

13.27

Макс.

14.35

Ключевые показатели

By Trading Economics

Доход

8.1M

-22M

Продажи

-40M

-1.3M

Прибыль на акцию

-0.03

Рентабельность продаж

1,694.961

Сотрудники

288

EBITDA

52M

27M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+63.35% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

7 мая 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-37M

199M

Предыдущая цена открытия

13.63

Предыдущая цена закрытия

14.06

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

Anika Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 апр. 2025 г., 23:54 UTC

Популярные акции

Stocks to Watch: Alphabet, Intel, AppFolio

24 апр. 2025 г., 23:51 UTC

Обсуждения рынка

Gold Edges Higher, Supported by U.S. Dollar Weakness -- Market Talk

24 апр. 2025 г., 23:46 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

24 апр. 2025 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Easing U.S.-China Trade Tensions -- Market Talk

24 апр. 2025 г., 23:37 UTC

Главные новости

Big Tech Braces for Tariff-Induced Advertising Slowdown -- WSJ

24 апр. 2025 г., 23:36 UTC

Главные новости

Tokyo Consumer Inflation Accelerates in April as Companies Raise Prices

24 апр. 2025 г., 23:13 UTC

Главные новости
Отчет

Google's Earnings Power Holds Up in Global Turbulence -- Update

24 апр. 2025 г., 23:09 UTC

Главные новости

Trump Initiatives Knocked Back in a New Round of Court Rulings -- 2nd Update

24 апр. 2025 г., 23:02 UTC

Приобретения, слияния, поглощения

SK Telecom to Sell 10.8M Kakao Shares via After-Hours Block Trading

24 апр. 2025 г., 23:02 UTC

Приобретения, слияния, поглощения

SK Telecom to Dispose of 2.4% Stake in Kakao to Raise KRW413.27B

24 апр. 2025 г., 22:51 UTC

Главные новости
Приобретения, слияния, поглощения

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

24 апр. 2025 г., 22:48 UTC

Главные новости

Walmart Walks the DEI Tightrope in Latest Proxy Statement -- Barrons.com

24 апр. 2025 г., 22:47 UTC

Обсуждения рынка

Intel Remains in Tough Position, CFRA Research Analyst Says -- Market Talk

24 апр. 2025 г., 22:38 UTC

Обсуждения рынка
Отчет

Tariffs Hurt Intel's 2Q Outlook as CFO Warns Economic Slowdown is Likely -- Market Talk

24 апр. 2025 г., 22:24 UTC

Отчет

Aluminum Corp. of China: Increase in Product Sales Supported 1Q Results >2600.HK

24 апр. 2025 г., 22:24 UTC

Отчет

Aluminum Corp. of China 1Q Rev CNY55.78B Vs. CNY48.96B >2600.HK

24 апр. 2025 г., 22:24 UTC

Обсуждения рынка
Отчет

Intel's Comeback Involves More Engineers, More In-Office Work -- Market Talk

24 апр. 2025 г., 22:23 UTC

Отчет

Aluminum Corp. of China 1Q Net CNY3.54B Vs. Net CNY2.23B >2600.HK

24 апр. 2025 г., 22:11 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

24 апр. 2025 г., 22:11 UTC

Обсуждения рынка
Отчет

Intel CEO: Layoffs Will Simplify Company Structure -- Market Talk

24 апр. 2025 г., 22:09 UTC

Главные новости
Отчет

Intel Cuts Outlook, Says Layoffs Are in Store -- Update

24 апр. 2025 г., 22:00 UTC

Обсуждения рынка
Отчет

T-Mobile's Key Subscriber Metric Disappoints Despite Earnings Beat -- Market Talk

24 апр. 2025 г., 21:39 UTC

Главные новости

Trump Initiatives Knocked Back in a New Round of Court Rulings -- WSJ

24 апр. 2025 г., 21:24 UTC

Главные новости
Отчет

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy. -- Barrons.com

24 апр. 2025 г., 21:24 UTC

Главные новости
Отчет

Google's Earnings Power Holds Up in Global Turbulence -- WSJ

24 апр. 2025 г., 21:23 UTC

Главные новости
Отчет

Intel Cuts Outlook, Says Layoffs Are in Store -- WSJ

24 апр. 2025 г., 21:04 UTC

Отчет

T-Mobile Reports Strong Earnings but Its Wireless Results Disappoint. The Stock Is Sliding. -- Barrons.com

24 апр. 2025 г., 21:03 UTC

Отчет

Agnico-Eagle Mines Believes Its Rev Structure Will Be Largely Unaffected by the Tariffs >AEM.T

24 апр. 2025 г., 21:03 UTC

Отчет

Agnico-Eagle Mines Total Expected Capex for 2025 Still Estimated at $1.75 B to $1.95 B >AEM.T

24 апр. 2025 г., 21:02 UTC

Отчет

Agnico-Eagle Mines Positioned to Achieve 2025 AISC Per Ounce Guidance of $1,250 to $1,300. >AEM.T

Сравнение c конкурентами

Изменение цены

Anika Therapeutics Inc Прогноз

Целевая цена

By TipRanks

63.35% рост

Прогноз на 12 месяцев

Средняя 23 USD  63.35%

Максимум 28 USD

Минимум 20 USD

Основано на мнении 3 аналитиков Wall Street, спрогнозировавших целевые цены для Anika Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

3 ratings

3

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

14.02 / 14.7324Поддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Bearish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.